New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Century Therapeutics, Inc. (IPSC) vs Vanda Pharmaceuticals Inc. (VNDA)
- Century Therapeutics, Inc. IPSC 1.17 −11.36%
- Vanda Pharmaceuticals Inc. VNDA 3.45 −5.99%
Century Therapeutics, Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Vanda Pharmaceuticals Inc. are of similar size ($239.7M and $235.2M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against 8.11%. Century Therapeutics, Inc. has the higher net margin (−19.1% vs −119.9%) and the higher return on invested capital (−71.5% vs −180.2%). Across the 16 metrics below, Century Therapeutics, Inc. leads on 12 and Vanda Pharmaceuticals Inc. on 4.
Valuation
Profitability
| Metric | IPSC | VNDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.59% | 70.18% |
| Operating margin | (28.42%) | (77.59%) | 0.00% |
| Net margin | (19.10%) | (119.87%) | 0.00% |
| Free cash flow margin | (99.74%) | — | 0.00% |
| Return on equity | (51.16%) | (82.55%) | (51.58%) |
| Return on assets | (38.96%) | (55.89%) | (45.91%) |
| Return on invested capital | (71.47%) | (180.19%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack